These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 2317923)

  • 1. Treatment of patients with heart failure.
    Cohn JN
    Circulation; 1990 Apr; 81(4):1440-1. PubMed ID: 2317923
    [No Abstract]   [Full Text] [Related]  

  • 2. Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.
    Ferdinand KC
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):993-1001. PubMed ID: 16292990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. The Large State Peer Review Organization Consortium.
    Arch Intern Med; 1997 May; 157(10):1103-8. PubMed ID: 9164376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of peripheral vasodilators in the immediate postoperative period following cardiac surgery: comparative study of the effects of dianhydrosorbitol dinitrate and sodium nitroprussate].
    Fortuna AB; Wada L; Lima CE; Baccarin V; Oliveira AA
    Arq Bras Cardiol; 1981 Oct; 37(4):335-9. PubMed ID: 6926957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Suppression of complex ventricular arrhythmias with isosorbide dinitrate in a case of congestive heart failure].
    Gnecchi M; De Marzio P; Morelli S; Aguglia F
    Cardiologia; 1985 May; 30(5):401-4. PubMed ID: 3833353
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of nitrates in acute therapy of heart failure with and without lung edema].
    Beck OA
    Z Kardiol; 1985; 74 Suppl 1():15-22. PubMed ID: 3922141
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilators in the treatment of congestive heart failure.
    Ciafone RA
    Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitrates in acute myocardial infarction.
    Taylor SH
    Scand J Clin Lab Invest Suppl; 1984; 173():27-32. PubMed ID: 6597542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure With Low Cardiac Output.
    Martyn T; Faulkenberg KD; Yaranov DM; Albert CL; Hutchinson C; Menon V; Estep JD; Nissen SE; Tang WHW; Starling RC
    J Am Coll Cardiol; 2019 Nov; 74(18):2326-2327. PubMed ID: 31672191
    [No Abstract]   [Full Text] [Related]  

  • 15. Successes and failures of current treatment of heart failure.
    Cleland JG; Swedberg K; Poole-Wilson PA
    Lancet; 1998 Aug; 352 Suppl 1():SI19-28. PubMed ID: 9736476
    [No Abstract]   [Full Text] [Related]  

  • 16. ABC of heart failure. Clinical features and complications.
    Watson RD; Gibbs CR; Lip GY
    BMJ; 2000 Jan; 320(7229):236-9. PubMed ID: 10642237
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypharmacy and comorbidity in heart failure.
    Masoudi FA; Krumholz HM
    BMJ; 2003 Sep; 327(7414):513-4. PubMed ID: 12958085
    [No Abstract]   [Full Text] [Related]  

  • 18. Heart failure: a medical hydra.
    Cleland JG
    Lancet; 1998 Aug; 352 Suppl 1():SI1-2. PubMed ID: 9736472
    [No Abstract]   [Full Text] [Related]  

  • 19. Is preventive medicine responsible for the increasing prevalence of heart failure?
    Coats AJ
    Lancet; 1998 Aug; 352 Suppl 1():SI39-41. PubMed ID: 9736479
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoxic hepatitis in patients with cardiac failure.
    Mohacsi P; Meier B
    J Hepatol; 1994 Nov; 21(5):693-5. PubMed ID: 7890881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.